Webinar Description: Prospective evidence demonstrates that non-ablative radiation dose improves local control without a meaningful impact on overall survival for patients with inoperable pancreas cancer. While the prescribed dose has historically been constrained due nearby GI organs at risk, the development of advanced treatment techniques has enabled the safe delivery of ablative hypofractionated radiation therapy. Emerging evidence suggests that dose intensification in selected patients achieves significantly improved long-term local control and overall survival.
Presenters:
Michael Chuong, MD, Miami Cancer Institute
Ann Raldow, MD, UCLA John Ng, MD, Weill Cornell Medicine
Chris Crane, MD, Memorial Sloan Kettering Cancer Center
Moderated By: Michael Chuong, MD, Miami Cancer Institute
This webinar has been supported by an unrestricted grant from ViewRay. This event is under the directed supervision of AMEDCO and Sponsor has had no part in the planning or delivery process.
